FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel derivatives of camptothecin, selected from the group, consisting of:CPT1: 9-tert-butyloxyethyloxim-10-[(4'-piperidinylpiperidinyl)carbonyloxy]camptothecin; CPT2: 9-tert-butyloxyethyloxim-10-hydroxycamptothecin; CPT3: 9-tert-butyloxyethyloxim -10-fluorocanptothecin; CPT7: 9-tert-butyloxyethyloximcamptothecin; and CPT8: 9-tert-butyloxyethyloxim-10-acetoxycamptothecin, or their salts, pharmaceutical compositions, possessing antitumour activity, based on said compounds and to their application.
EFFECT: compounds have good water solubility and stability, as well as high selectivity among other medications of the same category, very large therapeutic index and thereupon are perspective for application as therapeutic means for tumour treatment.
5 cl, 4 tbl, 3 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CAMPTOTECIN DERIVATIVES AND APPLICATION THEREOF | 2007 |
|
RU2411244C2 |
| CAMPTOTHECIN DERIVATIVES WITH ANTICANCER ACTIVITY | 2007 |
|
RU2441009C2 |
| CAMPTOTHECIN DERIVATIVES WITH ANTICANCER ACTIVITY | 2007 |
|
RU2450007C2 |
| DERIVATIVES OF CAMPTOTHECIN, THEIR N-OXIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2165935C2 |
| CARBOCYCLIC ANALOGS OF 20(S)-CAMPTOTHECIN, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1997 |
|
RU2200163C2 |
| CAMPTOTHECIN DERIVATIVES WITH ANTICANCER ACTIVITY | 2007 |
|
RU2450008C2 |
| CAFFEIC ACID BIOLOGICALLY AVAILABLE FOR ORAL USE, ASSOCIATED WITH ANTITUMOUR MEDICINAL AGENTS | 2007 |
|
RU2456265C2 |
| PARP-INHIBITING COMPOUNDS AND COMPOSITIONS, AND METHODS FOR USING THEM | 2008 |
|
RU2485122C2 |
| DERIVATIVE OF 3Т-ETHYNILCYTIDINE | 2007 |
|
RU2441876C2 |
| PROTEINKINASE INHIBITORS, METHOD FOR OBTAINING THEREOF AND MEDICAL APPLICATION | 2016 |
|
RU2749437C2 |
